Dr. Reddy's Laboratories Limited (``Dr. Reddy's''), together with its subsidiaries, launches the recommended public offer to acquire all the issued and outstanding shares of OctoPlus NV, a service-based specialty pharmaceutical company, at an offer price of EUR 0.52 per share.
58852
Dr. Reddy's Laboratories launches public offer to acquire OctoPlus shares
158825
Nokia takes stake in Obopay
91093
Nampak to sell European cartons and healthcare operations to Maximus Holding II
79889
Merck buys drug rival Schering-Plough
169398
Pfizer announces commencement of tender offer for all outstanding shares of Encysive Pharmaceuticals Inc.
112080
Solutia initiates stock offering
4676
Fortis Healthcare has target of Rs 170:
27122
Verona Pharma plc - Issue of equity to raise approximately GBP3 million
10363
NuVasive to acquire Osteocel biologics business from Osiris Therapeutics
23120
CA acquires business software maker Oblicore
138125
Platinex issues common shares
12269
Fluidigm plans initial public offering
73563
Valeant Pharmaceuticals to acquire iNova
116309
Sirona Dental Systems says shareholder Sirona Holdings offering 178.1 million in common stock
28514
Fortis Healthcare acquires 74.59% stake in Super Religare Laboratories
47295
Countplus finalises acquisitions
122787
Baxter buys blood disorder assets from Archemix